Trial intelligence / Profile preview

SPM 927 in Postherpetic Neuralgia

NCT00861068Phase 2Completed

Sponsor
UCB
Start
Feb 2002
Primary completion
Dec 2002
Modality
Small Molecules
01

Overview

A Phase 2 trial of lacosamide in postherpetic neuralgia (PHN), sponsored by UCB. Started Feb 2002; status: completed.

02

Drugs

lacosamide
03

Conditions

postherpetic neuralgia (PHN)

Beyond the preview

Go deeper on NCT00861068.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00861068.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call